Wave Life Sciences Ltd. Business Finance Contracts & Agreements

46 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 3 to Open Market Sale Agreement between Wave Life Sciences Ltd. and Jefferies LLC
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
2024
Wave Life Sciences Ltd. Form of Pre-Funded Warrant to Purchase Ordinary Shares
Warrant Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2024
Underwriting Agreement for Offering of Ordinary Shares and Pre-Funded Warrants by Wave Life Sciences Ltd. with J.P. Morgan Securities LLC and Leerink Partners LLC
Underwriting Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2024
Description of Registered Securities of Wave Life Sciences Ltd. under Section 12 of the Exchange Act
Stock Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2024
Underwriting Agreement for 20,000,000 Ordinary Shares of Wave Life Sciences Ltd. with J.P. Morgan Securities LLC and Leerink Partners LLC
Underwriting Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2023
Wave Life Sciences Ltd. Form of Pre-Funded Warrant to Purchase Ordinary Shares (2022)
Warrant Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2022
Underwriting Agreement between Wave Life Sciences Ltd. and SVB Securities LLC for Offering of Ordinary Shares and Pre-Funded Warrants (June 14, 2022)
Underwriting Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2022
Amendment No. 2 to Open Market Sale Agreement between Wave Life Sciences Ltd. and Jefferies LLC
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
2022
Wave Life Sciences Ltd. 2021 Equity Incentive Plan Non-Qualified Share Option Agreement with Participant
Warrant Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2021
Underwriting Agreement for 8,333,334 Ordinary Shares of Wave Life Sciences Ltd. with Jefferies LLC, SVB Leerink LLC, and Mizuho Securities USA LLC
Underwriting Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2020
Description of Securities Registered under Section 12 of the Exchange Act – Wave Life Sciences Ltd.
Registration Rights Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
2020
Form of Non-qualified Share Option Agreement for UK Participants under the 2014 Equity Plan, effective as of January 1, 2018
Stock Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2019
Form of Restricted Share Unit Agreement under the 2014 Equity Plan, effective as of January 1, 2018
Stock Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2019
Form of Non-qualified Share Option Agreement under the 2014 Equity Plan, effective as of January 1, 2018
Stock Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2019
Underwriting Agreement, dated January 24, 2019, by and among the Company, Jefferies LLC, SVB Leerink LLC and Mizuho Securities USA LLC
Underwriting Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2019
Wave Life Sciences Ltd. 2014 Equity Incentive Plan Non-Qualified Share Option Agreement (UK Participants)
Warrant Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2017
Wave Life Sciences Ltd. Non-Qualified Share Option Agreement under 2014 Equity Incentive Plan
Warrant Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2017
Underwriting Agreement for 4,166,667 Ordinary Shares of WAVE Life Sciences Ltd. with Jefferies LLC, Leerink Partners LLC, and Mizuho Securities USA LLC
Underwriting Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2017
WAVE Life Sciences Ltd. 2014 Equity Incentive Plan Non-Qualified Share Option Agreement with Participant
Warrant Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2016
WAVE Life Sciences Ltd. 2014 Equity Incentive Plan Incentive Share Option Agreement with Participant
Warrant Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2016
Description of Securities Registered Under Section 12 of the Exchange Act – Wave Life Sciences Ltd.
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2025
Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as Amended (Effective August 6, 2024)
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2024
Wave Life Sciences Ltd. Nasdaq Inducement Non-Qualified Share Option Agreement with Participant
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2024
Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as Amended (Effective August 1, 2023)
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2023
Description of Registered Securities of Wave Life Sciences Ltd. under Section 12 of the Exchange Act
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2023
Description of Registered Securities of Wave Life Sciences Ltd. under Section 12 of the Exchange Act
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2022
Description of Securities Registered under Section 12 of the Exchange Act – Wave Life Sciences Ltd.
Registration Rights Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2022
Wave Life Sciences Ltd. 2021 Equity Incentive Plan Restricted Share Unit Award Agreement (UK Participants)
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2021
Wave Life Sciences Ltd. 2021 Equity Incentive Plan Non-Qualified Share Option Agreement (UK Participants)
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2021
Wave Life Sciences Ltd. 2021 Equity Incentive Plan Restricted Share Unit Award Agreement
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2021
Wave Life Sciences Ltd. 2021 Equity Incentive Plan
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2021
Wave Life Sciences Ltd. 2021 Performance-Based Restricted Share Unit Award Agreement under 2014 Equity Incentive Plan
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2021
Wave Life Sciences Ltd. 2014 Equity Incentive Plan Amended and Restated Performance-Based Restricted Share Unit Award Agreement (March 2021)
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2021
Description of Securities Registered Under Section 12 of the Exchange Act – Wave Life Sciences Ltd.
Registration Rights Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
DE
2021
Wave Life Sciences Ltd. Nasdaq Inducement Non-Qualified Share Option Agreement with Participant
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
NY
2020
Amendment No. 1 to Investors’ Rights Agreement by and among Wave Life Sciences Ltd. and Certain Investors
Investor Rights Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
2018
Wave Life Sciences Ltd. Restricted Share Unit Award Agreement under 2014 Equity Incentive Plan
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2017
Wave Life Sciences Ltd. 2014 Equity Incentive Plan Incentive Share Option Agreement with Participant
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2017
WAVE Life Sciences Ltd. 2014 Equity Incentive Plan, as Amended
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
2017
Wave Life Sciences Ltd. 2014 Equity Incentive Plan Restricted Share Unit Agreement with Participant
Equity Distribution Agreements
Wave Life Sciences Ltd.
Pharmaceuticals
MA
2016